Biocryst Pharmaceuticals Inc (BCRX)

Operating Cash Flow Growth

2039.89%

TTM · Period ending:

BCRX logo

BCRX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported2039.89%
BCRX TTM Cash from Operations YoY % (-18.46% → 2039.89%)
High-resolution chart · PNG

BCRX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
2,039.8942%
1,248.1298%
737.1492%
190.0781%
120.052%
74.4821%
45.3233%
49.374%
31.6036%
22.9922%
41.2166%
35.4265%
23.977%
17.2285%
-13.853%
-10.4466%
4.7391%
9.1457%
-3.6009%
-49.8054%
-83.2285%
-103.7407%
-53.1702%
0.0931%
16.3859%
14.0557%
3.2204%
-30.3695%
-95.6139%
-91.1458%
-124.9836%
-116.8403%
-35.7905%
-21.2091%
23.008%
41.5529%
27.6594%
-52.7451%
-307.426%
-412.4979%
-608.475%
15.265%
65.9775%
58.2602%
71.5138%
-37.1619%
-45.311%
-0.451%
13.3799%
33.1692%
29.0585%
15.4464%
0.4328%
-20.466%
-15.9561%
-0.7768%
-0.6022%
19.9538%
-12.9465%
-160.2107%
-265.0495%
-205.2955%
-76.0599%
56.898%
71.1488%
51.4546%
22.3023%
6.0264%
-0.0771%
2.563%
16.4974%
-35.4911%
3.0415%
41.9383%
-64.3369%
-292.0614%
-4,210.7121%
-626.5418%
34.8445%
73.5405%
103.7711%
143.8528%
-28.6195%
-49.0145%
-41.9537%
-52.6049%
-62.1234%
-43.7702%
-31.8729%
1.7107%
31.5818%
38.256%
31.6965%
7.0761%
-61.0875%
-100.9149%
-88.2201%
-80.5772%
-219.6865%
-409.8728%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.